CDC Draft Guidelines Could Curb Opioid Prescribing


Draft guidelines from the US Centers for Disease Control and Prevention (CDC) could sharply reduce the role opioids play in primary care-based pain management.

Draft guidelines from the US Centers for Disease Control and Prevention (CDC) could sharply reduce the role opioids play in primary care-based pain management.

During a recent webinar, the CDC outlined 12 new draft guidelines for opioid prescribing in primary care settings.

The proposed recommendations address the lack of consistency in opioid prescribing practices across primary care providers, as well as insufficient provider training on the powerful painkillers’ risks and benefits.

Prescription opioid sales have increased 300% since 1999, but there has not been a general increase in the amount of pain reported, the CDC said.

To address this, the CDC focused its draft guidelines on the following major clinical practice areas:

· Determining when to initiate or continue opioids for chronic pain outside of end-of-life care.

· Opioid selection, dosage, duration, follow-up, and discontinuation.

· Assessing risk and addressing harms of opioid use.

The first recommendation calls for non-opioid pharmacological therapy and non-pharmacological therapy to be first-line treatment options for chronic pain. Instead of selecting opioids by default, providers should only consider prescribing the analgesics if the anticipated benefits for both pain and function are expected to outweigh risks.

As Caleb Alexander, MD, MS, recently explained, “Many patients, as with physicians, may overestimate the effectiveness of opioids and underestimate the risks, including their addictive potential.”

The draft guidelines also direct primary care providers “to establish treatment goals with all patients, including realistic goals for pain and function.”

Explicitly setting these goals will help providers track a patient’s progress, and if treatment benchmarks aren’t being met, then they can decide which part of the care plan should be reevaluated.

Steve Leuck, PharmD, recently wrote that when chronic pain is treated, “it appears the [opioid] dose is increased when the goal of treatment is not met,” whereas when treating most other conditions, “it is not common practice to continue increasing the dose of the medication until the target is achieved.”

Although the draft guidelines are targeted at opioid prescribing practices, pharmacists also have a responsibility to remain patient-focused when dispensing prescription pain medications.

“Pharmacists should not just say, ‘Let’s get the medication prescribed to the patient,’ but [rather], ‘Let’s get the right medication, for the right reason, at the right time, and in the best form to improve overall care,’” Rolee Pathak Das, PharmD, BCPS, clinical associate professor at the Rutgers University Ernesto School of Pharmacy, told Pharmacy Times.

Pharmacists dispensed 259 million opioid prescriptions in 2012, which translates to 1 bottle of analgesic pills for every American adult, according to government figures.

The draft guidelines were only available through the webinar and will not be made public by the CDC until they are final.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U -
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii |
Pharmacy Interior | Image Credit: Tyler Olson -
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi -
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen |
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/ |
Image credit: fidaolga -
Pharmacists checking inventory at hospital pharmacy- Image credit: Jacob Lund |
Young male pharmacist giving prescription medications to senior female customer in a pharmacy | Image Credit: Zamrznuti tonovi -
Related Content
© 2023 MJH Life Sciences

All rights reserved.